Solstice Advanced Materials Balances Margin Pain With Growth

Solstice Advanced Materials, Inc. ((SOLS)) has held its Q4 earnings call. Read on for the main highlights of the call.

Solstice Advanced Materials’ latest earnings call struck a cautiously optimistic tone as management balanced near‑term margin pressure against solid demand and a powerful backlog. Executives acknowledged compressed profitability from transitory costs, product‑mix shifts and plant downtime, but emphasized strong top‑line growth, balance sheet flexibility and a clear path to restoring roughly 25% EBITDA margins by 2026.

Revenue Growth — Full Year and Quarter

Solstice reported 2025 net sales of $3.9 billion, up 3% year over year, or about 6% when stripping out unusually strong 2024 nuclear sales. Fourth‑quarter net sales rose a faster 8% to $987 million, underscoring resilient demand even as earnings lagged due to temporary operational and cost headwinds.

Strong Organic Momentum

Underlying trends were firm, with Q4 organic net sales up 6%, driven by roughly 2.5% volume growth and about 4% pricing power. Foreign currency added roughly 2 percentage points, showing that both demand and pricing in core markets, rather than FX alone, supported the quarter’s revenue performance.

Segment Strength — Refrigerants & Nuclear

The Refrigerants & Applied Solutions segment posted 2025 net sales of $710 million, up 10% year over year, with refrigerants alone jumping 20% to $367 million. Nuclear sales climbed 39% to $111 million, backed by a backlog exceeding $2 billion and largely contracted production through 2030, giving long‑term revenue visibility.

Electronic Materials Demand and Capacity Investments

Electronic & Specialty Materials delivered net sales of $277 million, up 4%, with Electronic Materials the standout, rising 19% to $112 million. Management announced plans to double sputtering target capacity in Spokane to serve rapidly growing AI and data center markets, signaling confidence in durable electronics demand.

Backlog, Production Expansion, and Secular Tailwinds

The company’s backlog now tops $2 billion and includes plans for more than 10 kilotons of UF6 production in 2026, roughly 20% above planned 2024 capacity. Leadership highlighted structural growth drivers such as the nuclear renaissance, AI, data center build‑outs and rising defense spending as long‑term supports for volumes and pricing.

Financial Discipline and Capital Allocation

Return on invested capital sits near 19%, with net leverage around 1.5 times adjusted EBITDA and long‑term debt of $2.0 billion against $534 million of cash. Total liquidity of about $1.5 billion, including a $1.0 billion undrawn revolver, underpins Solstice’s ability to fund growth projects while maintaining conservative leverage.

Capital Deployment and Shareholder Return

Capital expenditures reached $408 million in 2025, up 38% year over year, as Solstice leaned into high‑return growth investments. The company also initiated a quarterly dividend of $0.75 per share and reiterated priorities of organic projects, selective acquisitions and preserving balance sheet strength for future cycles.

2026 Guidance and Margin Recovery Outlook

Management guided 2026 net sales to $3.9–$4.1 billion and adjusted EBITDA to $975–$1,025 million, implying low single‑digit revenue and mid‑single‑digit EBITDA growth at the midpoint. They expect Q1 2026 EBITDA margins near 25% and aim to sustain roughly 25% margins longer term, while nuclear is projected to deliver double‑digit EBITDA CAGR through 2030.

Profitability Compression — Q4 and FY EBITDA Declines

Despite revenue gains, profitability slipped, with full‑year adjusted standalone EBITDA down 4% to $957 million and margin at 24.6%. Q4 was more pressured, as EBITDA fell 20% to $189 million and margins dropped to 19.1%, reflecting rising costs, mix headwinds and operational disruptions.

Transitory Costs and TSA Impact

Management pointed to spin‑off related costs, including IT, logistics transitions and the unwind of an FX hedge, as temporary drags on earnings. They also flagged an expected $30 million cost impact in 2026 from transition service agreements, weighted to the first half, before those expenses roll off and margins normalize.

Refrigerants Product-Mix & Margin Headwind

The shift toward low global warming potential refrigerants, or HFOs, weighed on 2025 margins as the product mix and imported volumes proved less profitable in the transition phase. Executives anticipate these mix‑related headwinds will persist near term but see future aftermarket opportunities improving pricing and margins over time.

Plant Downtime, Under-absorption and Destocking

Plant downtime and under‑absorption reduced fixed‑cost efficiency and hurt segment profitability across several product lines. Healthcare packaging sales fell 25% year over year as customers destocked, though management believes most of the destocking is now behind them, setting up for a potential rebound.

Segment Softness — Building Solutions and Specialty Chemicals

Building Solutions & Intermediates net sales declined 5% to $181 million, pressured by weaker construction activity. Research & Performance Chemicals fell 3%, also tied to softness in construction‑linked specialty additives, illustrating ongoing cyclical headwinds in building‑related markets.

Safety & Defense Near-Term Order Timing Volatility

Safety and Defense Solutions sales decreased 10% in 2025 due to lower volumes driven by order timing rather than lost business. While management remains confident in long‑term growth supported by rising defense budgets, they cautioned that quarterly results will likely remain choppy as orders shift between periods.

One-time Nuclear Loan Return Reduces 2026 Revenue

A final nuclear product‑loan return related to Metropolis Works will limit material available for open‑market sales in 2026, cutting revenue by about $30 million. The company estimates this will trim roughly $10 million from 2026 EBITDA, but emphasized this is a non‑recurring headwind that clears after next year.

Adjusted EBITDA Less CapEx and Cash Conversion

Adjusted EBITDA less CapEx dropped 21% in 2025 to $549 million as higher capital spending and lower EBITDA squeezed free cash flow. Cash conversion finished at 57%, reflecting the investment cycle and margin pressure, but management expects improvement as major projects ramp and transitory costs fade.

Forward-Looking Guidance and Outlook

Solstice’s 2026 guidance assumes modest revenue growth, mid‑single‑digit EBITDA expansion at the midpoint and capital spending of $400–$425 million. Management also expects more than 10 kilotons of nuclear production in 2026, a roughly $30 million TSA cost drag and a similar revenue headwind from nuclear loan returns, but still targets a durable return to about 25% EBITDA margins.

Solstice’s earnings call painted a picture of a company in investment mode, accepting near‑term margin pressure to position for durable growth in nuclear, refrigerants and electronic materials. For investors, the key watchpoints will be how quickly transitory costs unwind, how margins track back toward 25% and whether secular demand in energy, AI and defense continues to translate into rising cash generation.